Lv1
30 积分 2024-01-11 加入
Blood . 2026 May 1:blood.2025032145. doi: 10.1182/blood.2025032145
4个月前
已关闭
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial
5个月前
已完结
Outcomes of radiation integrated with T-cell–engaging bispecific antibodies in relapsed/refractory multiple myeloma
6个月前
已完结
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas
8个月前
已完结
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma
1年前
已完结
Multi‐Institutional Study of ALK‐Positive Large B‐Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies
1年前
已完结
皖公网安备34019202002308
